Eloralintide
A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight
Eli Lilly · Phase 1 · Completed · Enrollment 30
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |